Exiqon A/S

Exiqon is a Danish biotech company focused on the development of enabling technology platforms and novel DNA- and immuno-diagnostic products against common genetic diseases, in particular, cardio-vascular, diabetic and other chronic and degenerative diseases. In other fields Exiqon is a potential technology partner for licensees Exiqon's IPR includes LNA (Locked Nucleic Acids) and a universal method for the covalent coupling of diagnostic molecules to solid supports.

Activity:

- Research & Development

Product / Technology type(s) covered:

- Bio
- Diagnostics
- Technology

Therapeutic targets:

- Genetics

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: